-
71.发明公开Organic fuel cell with reduced crossover 失效Organische Brennstoffzelle mit gemindertemReaktantenübertritt
公开(公告)号：EP1498975A2
公开(公告)日：2005-01-19
申请号：EP04019945.7
申请日：1994-10-18
发明人： Surampudi, Subbarao , Narayanan, Sekharipuram R. , Vamos, Eugene , Frank, Harvey A. , Halpert, Gerald , Olah, George A. , Prakash, G.K. Surya
CPC分类号： H01M4/8605 , H01M4/8853 , H01M4/8892 , H01M4/921 , H01M4/926 , H01M4/928 , H01M8/04119 , H01M8/04186 , H01M8/1004 , H01M8/1009 , H01M8/1023 , H01M8/1039 , H01M8/1041 , H01M8/1046 , H01M8/22 , H01M8/2455 , H01M2004/8684 , H01M2300/0082 , Y02P70/56
摘要： A liquid organic fuel cell is provided which employs a solid electrolyte membrane. An organic fuel, such as a methanol/water mixture, is circulated past an anode of a cell while oxygen or air is circulated past a cathode of the cell. The cell solid electrolyte membrane is preferably fabricated from Nafion™. Additionally, a method for improving the performance of carbon electrode structures for use in organic fuel cells is provided wherein a high surface-area carbon particle/Teflon™-binder structure is immersed within a Nafion™/methanol bath to impregnate the electrode with Nafion™. A method for fabricating an anode for use in a organic fuel cell is described wherein metal alloys are deposited onto the electrode in an electrodeposition solution containing perfluorooctanesulfonic acid. A fuel additive containing perfluorooctanesulfonic acid for use with fuel cells employing a sulfuric acid electrolyte is also disclosed. New organic fuels, namely, trimethoxymethane, dimethoxymethane, and trioxane are also described for use with either conventional or improved fuel cells.
摘要翻译： 提供一种使用固体电解质膜的液体有机燃料电池。 诸如甲醇/水混合物的有机燃料循环通过电池的阳极，同时氧气或空气循环通过电池的阴极。 细胞固体电解质膜优选由Nafion TM制造。 另外，提供了一种用于改善用于有机燃料电池的碳电极结构的性能的方法，其中将高表面积碳颗粒/ Teflon TM粘合剂结构浸入Nafion TM /甲醇浴中以用Nafion TM浸渍电极 。 描述了一种用于制造用于有机燃料电池的阳极的方法，其中将金属合金沉积在含有全氟辛烷磺酸的电沉积溶液中的电极上。 还公开了一种用于与使用硫酸电解质的燃料电池一起使用的全氟辛烷磺酸的燃料添加剂。 还描述了新的有机燃料，即三甲氧基甲烷，二甲氧基甲烷和三恶烷，用于常规或改进的燃料电池。
-
公开(公告)号：EP1489674A3
公开(公告)日：2005-01-12
申请号：EP04019940.8
申请日：1994-10-18
发明人： Surampudi, Subbarao , Narayanan, Sekharipuram R. , Vamos, Eugene , Frank, Harvey A. , Halpert, Gerald , Olah, George A. , Prakash, G.K. Surya
CPC分类号： H01M4/8605 , H01M4/8853 , H01M4/8892 , H01M4/921 , H01M4/926 , H01M4/928 , H01M8/04119 , H01M8/04186 , H01M8/1004 , H01M8/1009 , H01M8/1023 , H01M8/1039 , H01M8/1041 , H01M8/1046 , H01M8/22 , H01M8/2455 , H01M2004/8684 , H01M2300/0082 , Y02P70/56
摘要： A liquid organic fuel cell is provided which employs a solid electrolyte membrane. An organic fuel, such as a methanol/water mixture, is circulated past an anode of a cell while oxygen or air is circulated past a cathode of the cell. The cell solid electrolyte membrane is preferably fabricated from Nafion™. Additionally, a method for improving the performance of carbon electrode structures for use in organic fuel cells is provided wherein a high surface-area carbon particle/Teflon™-binder structure is immersed within a Nafion™/methanol bath to impregnate the electrode with Nafion™. A method for fabricating an anode for use in a organic fuel cell is described wherein metal alloys are deposited onto the electrode in an electrodeposition solution containing perfluorooctanesulfonic acid. A fuel additive containing perfluorooctanesulfonic acid for use with fuel cells employing a sulfuric acid electrolyte is also disclosed. New organic fuels, namely, trimethoxymethane, dimethoxymethane, and trioxane are also described for use with either conventional or improved fuel cells.
-
73.发明授权Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints 失效化学交联的超高分子量聚乙烯为人造人体关节
公开(公告)号：EP0722973B1
公开(公告)日：2003-12-17
申请号：EP96300113.6
申请日：1996-01-05
发明人： Salovey, Ron , Shen, Fu-Wen , McKellop, Harry A.
CPC分类号： A61F2/30 , A61F2/3094 , A61F2/32 , A61F2/34 , A61F2/468 , A61F2002/30233 , A61F2002/3082 , A61F2002/30879 , A61F2002/3611 , A61F2230/0069 , A61L27/16 , B29B13/08 , B29C43/00 , B29C43/16 , B29C71/0063 , B29C2035/085 , B29K2023/0683 , B29K2105/24 , B29K2995/0087 , B29K2995/0089 , B29L2031/7532 , C08J5/00 , C08J7/047 , C08J2323/06 , C08L23/06
-
74.发明授权PROGESTOGEN-FREE FORMULATIONS OF GnRH AND ESTROGEN FOR TREATING BENIGN GYNECOLOGICAL DISORDERS 失效促性腺激素释放激素和雌激素的良性妇科疾病的治疗孕激素-FREE配方
公开(公告)号：EP0748190B1
公开(公告)日：2003-07-30
申请号：EP94917349.6
申请日：1994-05-12
CPC分类号： A61K9/1647 , A61K9/0036 , A61K38/09 , Y10S424/14 , A61K31/567 , A61K31/566 , A61K31/565 , A61K2300/00
摘要： Compositions and methods which are effective to treat benign gynecological disorders for extended periods of time in women in who the risk of endometrial stimulations is minimized or absent are described, wherein an effective amount of a gonadotropin hormone releasing hormone composition and an effective amount of an estrogenic composition are provided over a period of time, optionally with addition of an androgenic composition.
-
公开(公告)号：EP1200470A2
公开(公告)日：2002-05-02
申请号：EP00952571.8
申请日：2000-08-04
发明人： KRAFFT, Grant, A. , KLEIN, William, L. , CHROMY, Brett, A. , LAMBERT, Mary, P. , FINCH, Caleb, E. , MORGAN, Todd , WALS, Pat , ROZOVSKY, Irina , BARLOW, Ann
CPC分类号： C07K14/4711 , A61K38/00
摘要： The invention provides amyloid beta-derived dementing ligands (ADDLs) that comprise amyloid β protein assembled into globular non-fibrillar oligomeric structures capable of activating specific cellular processes. The invention also provides methods for assaying the formation, presence, receptor protein binding and cellular activity of ADDLs, as well as compounds that block the formation or activity of ADDLs, and methods of identifying such compounds. The invention further provides methods of using ADDLs, and modulating ADDL formation and/or activity, inter alia in the treatment of learning and/or memory disorders.
-
公开(公告)号：EP0958714A1
公开(公告)日：1999-11-24
申请号：EP97953361.0
申请日：1997-12-23
CPC分类号： H05B33/12 , H01L27/3211 , H01L27/322 , H01L51/5036 , H05B33/10 , Y10S428/917
摘要： A multicolor display device includes a transparent substrate (22), red and green fluorescent dyes (21) ink jet printed onto the substrate, a conductive layer (23) deposited over the red and green dye, an organic blue light emitting layer (24) deposited over the conductive layer, and an electrical contact deposited onto the blue light emitting layer.
-
公开(公告)号：EP0945049A1
公开(公告)日：1999-09-29
申请号：EP97930226.0
申请日：1997-06-25
CPC分类号： C09K11/06 , H01L51/5012 , Y10S428/917
摘要： Disclosed herein are novel dopant compounds of Formula (I), wherein those compounds are used in organic light emitting devices (OLED's) for device elements capable of emitting light of wavelengths associated with saturated red emissions. Also disclosed are OLED's utilizing device elements comprising the above compounds and display devices based on those OLED's.
-
公开(公告)号：EP0689455A1
公开(公告)日：1996-01-03
申请号：EP94911551.0
申请日：1994-03-10
CPC分类号： A61K31/70 , C07K16/10 , C07K16/1063 , C07K16/18 , C07K2317/34
摘要： Therapeutic strategies for the treatment of immunoinfective cluster virus infections in humans involving the use of antibodies or fragments thereof which are characteristic of autoantibodies produced by patients affected with systemic rheumatic disorders and cross-react with epitopes on an immunoinfective cluster virus. Additional therapeutic strategies include the use of U1 RNA or fragments thereof to treat said viral infections.
摘要翻译： 用于治疗人免疫感染簇病毒感染的治疗策略涉及使用抗体或其片段，所述抗体或片段是由患有全身性风湿病的患者产生的自身抗体的特征并与免疫感染簇病毒上的表位交叉反应。 另外的治疗策略包括使用U1 RNA或其片段来治疗所述病毒感染。
-
公开(公告)号：EP0662087A1
公开(公告)日：1995-07-12
申请号：EP93914393.0
申请日：1993-06-04
IPC分类号： A61K38 , A61P1 , A61P3 , A61P7 , A61P9 , A61P11 , A61P25 , A61P27 , A61P31 , A61P33 , A61P35 , A61P37 , A61P43 , C07H21 , C07K1 , C07K14 , C12N1 , C12N9 , C12N15 , C12P21
CPC分类号： C07K14/811 , A61K38/00 , C07K14/475
摘要： The present invention relates to a purified retinal pigmented epithelium derived neurotrophic factor composition and a method for purifying such a retinal pigmented epithelium neurotrophic factor. The present invention also relates to a recombinant DNA molecule comprising a gene encoding a retinal pigmented epithelium derived neurotrophic factor having the DNA sequence or the amino acid sequence in SEQ ID NO 1 and to an organism transformed with the recombinant DNA molecule. In addition, the present invention relates to a method of treating tumors, ocular diseases, nerve injuries, and conditions resulting from the activity of serine proteases, which comprises administering retinal epithelium derived neurotrophic factor.
-
80.发明授权
公开(公告)号：EP1729327B2
公开(公告)日：2022-08-10
申请号：EP06016911.7
申请日：2000-05-11
-
-
-
-
-
-
-
-
-
搜索结果
203 条记录 (耗时 0.03 秒)
